The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in income, its intellectual property lapse created a flood of knock-off medications, significantly diminishing its position . While certain pharmaceutical companies may attempt to capitalize on mal